Related Experiment Video
Updated: Jun 4, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Chronic viral hepatitis in kidney transplantation
Janna Huskey1, Alexander C Wiseman
1Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO 80045, USA.
Insights
Kidney transplantation is now possible for patients with chronic hepatitis B (HBV) or C (HCV) infection due to advances in antiviral therapies. This improves survival compared to dialysis, even allowing organ sharing between infected donors and recipients.
Area of Science:
- Nephrology
- Hepatology
- Transplantation Immunology
Background:
- Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were previously absolute contraindications for kidney transplantation.
- Advances in antiviral therapies have transformed the management of HBV and HCV, creating new opportunities for potential kidney transplant recipients.
Purpose of the Study:
- To evaluate the feasibility and outcomes of kidney transplantation in patients with chronic HBV or HCV infection.
- To discuss the role of pretransplantation antiviral therapy and organ allocation strategies for these patient populations.
Main Methods:
- Review of current medical management strategies for HBV and HCV in kidney transplant candidates.
- Analysis of patient survival and liver disease progression in transplanted versus dialysis patients.
- Consideration of simultaneous liver-kidney transplantation for advanced liver disease.
- Evaluation of organ allocation protocols using HBV/HCV-infected donor organs.
Main Results:
- Effective antiviral therapies with minimal adverse effects and drug resistance are available for HBV infection.
- Pretransplantation antiviral therapy for HCV infection shows promise but faces challenges with adverse effects and viral eradication.
- Kidney transplantation offers superior survival compared to dialysis for patients without advanced liver disease.
- Simultaneous liver-kidney transplantation is a viable option for patients with severe liver disease.
- Utilizing organs from HBV/HCV-infected donors for serologically matched recipients can expand the donor pool.
Conclusions:
- Chronic HBV and HCV infections are no longer absolute barriers to kidney transplantation.
- Careful patient selection, optimized antiviral therapy, and strategic organ allocation are crucial for successful transplantation in these patients.
- Kidney transplantation significantly improves survival for eligible patients with chronic viral hepatitis compared to long-term dialysis.
Abstract:
Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection in potential kidney transplant candidates-once considered absolute contraindications to kidney transplantation-no longer creates overt barriers to transplantation. Advances in the medical management of HBV and HCV infection have created opportunities for a substantial number of patients to be effectively treated with antiviral therapy before transplantation. For HBV infection, a number of new drugs enable clearance of the virus with minimal adverse effects and drug resistance. Pretransplantation antiviral therapy is advisable for patients with HCV infection, but adverse effects are common and viral eradication remains challenging. Regardless of viral clearance, pretransplant patients without bridging fibrosis (as confirmed by liver biopsy) or clinical stigmata of cirrhosis should be considered for kidney transplantation as survival is superior when compared to treatment with dialysis, and progression of liver disease is unlikely. For patients with advanced liver disease, simultaneous liver-kidney transplantation is an important consideration. These treatment advances further increase the burden of organ donor shortage; however, organs from deceased donors with chronic HBV or HCV infection could be efficiently allocated to certain individuals with a viral infection of the same type to increase the pool of available transplant organs.
Related Concept Videos
Kidney Transplant I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Hepatitis
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
